oa Southern African Journal of Gynaecological Oncology - Medicines Control Council approves Tarceva® in South Africa for treatment of non-small cell lung cancer : press release



Thousands of South African lung cancer patients could now live longer and with improved quality of life if they receive Tarceva® (erlonitib), a novel alternative to traditional chemotherapy, recently approved by the Medicines Control Council (MCC).


Article metrics loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error